William Link - Second Sight Independent Director
| EYESDelisted Stock | USD 4.14 0.20 4.61% |
Director
Dr. William J. Link, Ph.D., is Independent Director of the Company. Mr. Link has served as a member of our Board of Directors since 2003. Mr. Link is a cofounder and managing director of Versant Ventures, a VC firm specializing in earlystage investing in healthcare companies, since its inception in 1999. Prior to cofounding Versant Ventures, Mr. Link was a general partner at Brentwood VC from 1998 to present. Mr. Link also founded and served as chairman and CEO of Chiron Vision, a subsidiary of Chiron Corporation specializing in ophthalmic surgical products, from 1986 to 1997 which was sold to Bausch Lomb in 1997. Prior to Chiron Vision, Mr. Link founded in 1978 and served as President of American Medical Optics, a division of American Hospital Supply Corporationrationration, which was sold to Allergan in 1986. Mr. Link also served on the Board of AMOs successor company, Advanced Medical Optics which was acquired by Abbott in 2009, from 2002 to 2009. Mr. Link was an Assistant Professor in the Department of Surgery at the Indiana University School of Medicine from 1973 to 1976 since 2003.
| Age | 71 |
| Tenure | 21 years |
| Phone | 818 833-5000 |
| Web | www.secondsight.com |
Second Sight Management Efficiency
The company has return on total asset (ROA) of (10.74) % which means that it has lost $10.74 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (19.02) %, meaning that it created substantial loss on money invested by shareholders. Second Sight's management efficiency ratios could be used to measure how well Second Sight manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 199 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Second Sight Medical has a current ratio of 24.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Second Sight until it has trouble settling it off, either with new capital or with free cash flow. So, Second Sight's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Second Sight Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Second to invest in growth at high rates of return. When we think about Second Sight's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Masaaki Shintaku | Fast Retailing Co | 63 | |
| Russell Hardin | Genuine Parts Co | 61 | |
| Errol Glasser | Century Aluminum | 64 | |
| Donna Hyland | Genuine Parts Co | 60 | |
| Toru Hambayashi | Fast Retailing Co | 80 | |
| Mary Bullock | Genuine Parts Co | 70 | |
| John Holder | Genuine Parts Co | 66 | |
| Naotake Ohno | Fast Retailing Co | 69 | |
| Gary Fayard | Genuine Parts Co | 69 | |
| Gary Rollins | Genuine Parts Co | 70 | |
| Jenner Wood | Genuine Parts Co | 66 | |
| Wendy Needham | Genuine Parts Co | 67 | |
| Robert Loudermilk | Genuine Parts Co | 61 | |
| Wilhelm Jaarsveld | Century Aluminum | 33 | |
| Toru Murayama | Fast Retailing Co | 63 | |
| Elizabeth Camp | Genuine Parts Co | 69 | |
| Nobumichi Hattori | Fast Retailing Co | 60 | |
| John Johns | Genuine Parts Co | 69 | |
| Daniel Goldberg | Century Aluminum | 37 | |
| Takashi Nawa | Fast Retailing Co | 60 | |
| Jarl Berntzen | Century Aluminum | 51 | |
Management Performance
| Return On Equity | -19.02 | |||
| Return On Asset | -10.74 |
Second Sight Medical Leadership Team
Elected by the shareholders, the Second Sight's board of directors comprises two types of representatives: Second Sight inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Second. The board's role is to monitor Second Sight's management team and ensure that shareholders' interests are well served. Second Sight's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Second Sight's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Blake, CFO | ||
| Patrick Ryan, COO | ||
| Frank Vandeputte, Vice President General Manager | ||
| Anthony Moses, Commercial Vice President - Americas | ||
| Edward Randolph, VP of Manufacturing | ||
| Gregg Williams, Independent Director | ||
| Alfred Mann, Co-Founder, Chairman Emeritus, Member of Audit Committee, Member of Nominating and Governance Committee and Member of Compensation Committee | ||
| Jonathan McGuire, President CEO, Director | ||
| Stephen Okland, Commercial Vice President U.S. and Canada | ||
| Gregoire Cosendai, VP of European Operations | ||
| Steven Okland, Commercial Vice President U.S. and Canada | ||
| William Link, Independent Director | ||
| Thomas Miller, CFO | ||
| James Miller, Director - Manufacturing | ||
| Will McGuire, President CEO, Director | ||
| David Jacques, Vice President - Research & Development | ||
| Aaron Mendelsohn, Director | ||
| Robert Greenberg, President CEO, Director | ||
| Matthew Pfeffer, Independent Director |
Second Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Second Sight a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -19.02 | |||
| Return On Asset | -10.74 | |||
| Current Valuation | 11.54 M | |||
| Shares Outstanding | 39.41 M | |||
| Shares Owned By Insiders | 28.61 % | |||
| Shares Owned By Institutions | 7.01 % | |||
| Number Of Shares Shorted | 1.19 M | |||
| Price To Earning | (1.61) X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 616.54 X |
Pair Trading with Second Sight
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Second Sight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Second Sight will appreciate offsetting losses from the drop in the long position's value.Moving together with Second Stock
| 0.62 | MDT | Medtronic PLC Sell-off Trend | PairCorr |
Moving against Second Stock
| 0.72 | JPHLF | Japan Post Holdings | PairCorr |
| 0.7 | MZHOF | Mizuho Financial | PairCorr |
| 0.67 | BSX | Boston Scientific Corp Earnings Call This Week | PairCorr |
| 0.6 | EW | Edwards Lifesciences Corp Earnings Call This Week | PairCorr |
| 0.6 | ALGN | Align Technology Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Second Sight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Second Sight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Second Sight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Second Sight Medical to buy it.
The correlation of Second Sight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Second Sight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Second Sight Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Second Sight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Second Sight Medical information on this page should be used as a complementary analysis to other Second Sight's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Second Stock
If you are still planning to invest in Second Sight Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Second Sight's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |